The Angle from T. Rowe Price

Priyal Maniar and Elliot Shue, along with Jackie Fortner, delve into the enduring importance of oil and gas in the global energy mix and examine the intricate balance between long-term structural forces and short-term market shocks.

This 2025 highlights episode features memorable moments from Eric Veiel’s interviews with leading CEOs and executives across technology, health care, finance, and energy as they discuss how they navigate change, foster innovation, and adapt to disruption.

Join host Ritu Vohora for this special edition of “The Angle” as we focus on our 2026 Global Market Outlook. Our experts discuss AI-driven capex, macro risks vs. bullish signals, and highlight the potential broadening of financial markets.

Eli Lilly Chair and CEO Dave Ricks joins Eric Veiel, Head of Global Investments and CIO at T. Rowe Price Associates, to share his insights on the company’s major advancements in diabetes, obesity, and Alzheimer’s treatments.

OpenAI CFO Sarah Friar joins Eric Veiel, head of Global Investments and CIO at T. Rowe Price Associates, to discuss OpenAI’s explosive growth, global strategy, technology investments, and how AI agents are reshaping business and daily life.

Annie Duke—a former professional poker player and renowned author on behavioral science—discusses the science of decision making and how it can be applied to investing with Justin Thomson, head of the T. Rowe Price Investment Institute.

Annie Duke—a former professional poker player and renowned author on behavioral science—discusses the science of decision making and how it can be applied to investing with Justin Thomson, head of the T. Rowe Price Investment Institute.

Jane Fraser, CEO of Citi talks to Eric Veiel, head of Global Investments and CIO at T. Rowe Price Associates, about the challenges of being a CEO, why she is optimistic about the U.S. economy, and how Citi are using AI to increase productivity.

Eric Veiel, head of Global Investments and CIO at T. Rowe Price Associates, chats with David Rubenstein, Cofounder, and Harvey Schwartz, CEO, of Carlyle about its formation, the future for private investments, and their views on philanthropy.

In this episode of “The Angle,” Jennifer Martin is joined by health care portfolio manager Sal Rais to explore how new ways of treating disease are improving human health, and how breakthrough drugs can potentially create value for biotech innovators.